These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 26105375)

  • 1. PP052. The course of sFlt-1 and PLGF reflects different progression pattern in early- versus late-onset preeclampsia and HELLP syndrome.
    Schaarschmidt W; Rana S; Stepan H
    Pregnancy Hypertens; 2012 Jul; 2(3):269. PubMed ID: 26105375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the diagnostic utility of the sFlt-1/PlGF ratio versus PlGF alone for the detection of preeclampsia/HELLP syndrome.
    Stepan H; Hund M; Gencay M; Denk B; Dinkel C; Kaminski WE; Wieloch P; Semus B; Meloth T; Dröge LA; Verlohren S
    Hypertens Pregnancy; 2016 Aug; 35(3):295-305. PubMed ID: 27028698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The course of angiogenic factors in early- vs. late-onset preeclampsia and HELLP syndrome.
    Schaarschmidt W; Rana S; Stepan H
    J Perinat Med; 2013 Sep; 41(5):511-6. PubMed ID: 23612628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PP051. Prediction of preeclampsia with the sFlt-1/PLGF ratio: impact of the slope of repeated measurements.
    Schoofs K; Engels T; Pape J; Henrich W; Stepan H; Verlohren S
    Pregnancy Hypertens; 2012 Jul; 2(3):269. PubMed ID: 26105374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Predictive value of the sFlt1/PlGF ratio for the diagnosis of preeclampsia in high-risk patients].
    Husse S; Gottschlich A; Schrey S; Stepan H; Hoffmann J
    Z Geburtshilfe Neonatol; 2014 Feb; 218(1):34-41. PubMed ID: 24595913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PP058. The additive effect of plasma levels of sFlt-1/PLGF ratio following the risk classification using both blood pressure levels and uterine artery blood flow impedance in the second trimester on the later occurrence of preeclampsia.
    Ohkuchi A; Hirashima C; Takahashi K; Matsubara S; Suzuki M
    Pregnancy Hypertens; 2012 Jul; 2(3):273. PubMed ID: 26105381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PP086. The modern search for possible predictors of preeclampsia in the first trimester of pregnancy (preliminary study).
    Khodzhaeva ZS; Ivanets TY; Alexeeva ML; Kholin AM; Akatyeva AS; Vavina OV; Sukhikh GT
    Pregnancy Hypertens; 2012 Jul; 2(3):287. PubMed ID: 26105408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter evaluation of the first automated Elecsys sFlt-1 and PlGF assays in normal pregnancies and preeclampsia.
    Schiettecatte J; Russcher H; Anckaert E; Mees M; Leeser B; Tirelli AS; Fiedler GM; Luthe H; Denk B; Smitz J
    Clin Biochem; 2010 Jun; 43(9):768-70. PubMed ID: 20206155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PP117. Measurement of sFlt-1 and PlGF for prediction of pregnancy associated diseases.
    Stubert J; Ullmann S; Bolz M; Bohlmann M; Külz T; Gerber B; Reimer T
    Pregnancy Hypertens; 2012 Jul; 2(3):303. PubMed ID: 26105439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PP059. Angiogenic factors and risk of preeclampsia related adverse outcomes in twin pregnancies.
    Rana S; Hacker M; Merport A; Salahuddin S; Verlohren S; Perschel F; Karumanchi SA
    Pregnancy Hypertens; 2012 Jul; 2(3):273-4. PubMed ID: 26105382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PP176. SFLT-1: A possibility of precocious diagnosis of preeclampsia.
    Olmos CS; Macedo MA; Pereira RM; Augusto V; Garcia JM; Panico VJ; Souza EV; Sato JL; Saito M; Sousa FL; Sass N
    Pregnancy Hypertens; 2012 Jul; 2(3):335-6. PubMed ID: 26105497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients.
    Verlohren S; Herraiz I; Lapaire O; Schlembach D; Moertl M; Zeisler H; Calda P; Holzgreve W; Galindo A; Engels T; Denk B; Stepan H
    Am J Obstet Gynecol; 2012 Jan; 206(1):58.e1-8. PubMed ID: 22000672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia.
    Verlohren S; Galindo A; Schlembach D; Zeisler H; Herraiz I; Moertl MG; Pape J; Dudenhausen JW; Denk B; Stepan H
    Am J Obstet Gynecol; 2010 Feb; 202(2):161.e1-161.e11. PubMed ID: 19850276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. sFlt-1/PlGF ratio as a prognostic marker of adverse outcomes in women with early-onset preeclampsia.
    De Oliveira L; Peraçoli JC; Peraçoli MT; Korkes H; Zampieri G; Moron AF; Sass N
    Pregnancy Hypertens; 2013 Jul; 3(3):191-5. PubMed ID: 26106033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PP006. The comparison of serum VEGF and sFlt-1 on preeclampsia and eclampsia pregnant woman before and after delivery at Ulin Hospital, Banjarmasin, Indonesia.
    Akbar A; Abimanyu B; Dachlan EG; Abadi A
    Pregnancy Hypertens; 2012 Jul; 2(3):243. PubMed ID: 26105329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsia.
    Buhimschi CS; Norwitz ER; Funai E; Richman S; Guller S; Lockwood CJ; Buhimschi IA
    Am J Obstet Gynecol; 2005 Mar; 192(3):734-41. PubMed ID: 15746665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated systemic galectin-1 levels characterize HELLP syndrome.
    Schnabel A; Blois SM; Meint P; Freitag N; Ernst W; Barrientos G; Conrad ML; Rose M; Seelbach-Göbel B
    J Reprod Immunol; 2016 Apr; 114():38-43. PubMed ID: 26956510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different profiles of circulating angiogenic factors and adipocytokines between early- and late-onset pre-eclampsia.
    Masuyama H; Segawa T; Sumida Y; Masumoto A; Inoue S; Akahori Y; Hiramatsu Y
    BJOG; 2010 Feb; 117(3):314-20. PubMed ID: 20015306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PP054. Predicting preeclampsia at late mid-term pregnancy before occurrence of clinical symptoms: Clinical utility of biomarkers and clinical parameters in a low-risk population.
    Forest JC; Massé J; Bujold E; Lafond J; Charland M; Rousseau F; Giguère Y
    Pregnancy Hypertens; 2012 Jul; 2(3):271. PubMed ID: 26105377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PP122. Lack of correlation between placental weight and circulating soluble fms-like tyrosine kinase-1 and placental growth factor suggests trophoblastic activity as a major contributor to the serum pool.
    Wataganara T; Pratumvinit B; Leetheerakul J; Pongprasobchai S; Lahfahroengron P; Pooliam J
    Pregnancy Hypertens; 2012 Jul; 2(3):305. PubMed ID: 26105444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.